deCODE genetics is a global leader in analyzing and understanding the human genome. Founded in 1996 and headquartered in Iceland, the company has made significant strides in identifying genetic risk factors for numerous common diseases. Through its unique expertise and population resources, deCODE has been able to make groundbreaking discoveries in the field of biotechnology and healthcare. Its ultimate goal is to leverage this genetic information to develop innovative methods for diagnosing, treating, and preventing diseases.
The company's last investment was a Seed Round investment on 01 January 1998, with Atlas Venture as the investor. This investment has provided deCODE genetics with the necessary support to continue its pioneering work in decoding the intricacies of the human genome and furthering its research in disease prevention and treatment.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Seed Round | Unknown | 1 |
|
01 Jan 1998 |
No recent news or press coverage available for deCODE genetics.
We care about your data, and we'd love to use cookies make your experience better.
